0       0

2019 Scientific Sessions On-Demand


SSLIVE17 - Late Breaking Science III: Controversies in Contemporary Management of AS


Nov 16, 2019 5:30pm ‐ Nov 16, 2019 6:45pm


Credits: None available.

Description

Social Media ModeratorChris Malaisrie

Late Breaking Science III: Controversies in Contemporary Management of AS - Case Presentation: What Would You Do? - AHA Discussant

Global Comparison of a Rivaroxaban-Based Antithrombotic Strategy versus an Antiplatelet-Based Strategy After Transcathether Aortic Valve Replacement to Optimize Clinical Outcomes (GALILEO) Trial: Primary ResultsGeorge Dangas

DiscussantElaine Hylek

Randomized Clinical Trial Comparing a Rivaroxaban-Based Strategy with an Antiplatelet-Based Strategy for the Prevention of Subclinical Leaflet Thrombosis in Transcatheter Aortic Valves (GALILEO-4D)Ole De Backer

Discussant Victoria Delgado

Balloon-Expandable versus Self-Expandable TAVR on Paravalvular Regurgitation and 2-Year Mortality: A Propensity-Matched Comparison From the FRANCE-TAVI RegistryEric Van Belle

DiscussantDharam Kumbhani

Early Surgery versus Conventional Management for Asymptomatic Severe Aortic Stenosis - Duk-Hyun Kang

DiscussantRobert Bonow

Late Breaking Science III: Controversies in Contemporary Management of AS - Case Revisited and Discussion

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content